Benzinga | Aug 31, 2021 10:10AM EDT

UBS Maintains Buy on Catalent, Raises Price Target to $145

UBS analyst John Sourbeer maintains Catalent (NYSE:CTLT) with a Buy and raises the price target from $138 to $145.